Scott Henry
Stock Analyst at Alliance Global Partners
(1.71)
# 3,234
Out of 4,944 analysts
52
Total ratings
41.51%
Success rate
-3.31%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $1.73 | +73.41% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.17 | +221.89% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $4.67 | +28.48% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $3.06 | +226.96% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.83 | +233.17% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $7.31 | +16.28% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.25 | +220.00% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $1.93 | +677.20% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.46 | +2,499.65% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $6.87 | +9.25% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $11.15 | +16.59% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $41.30 | -41.89% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $20.33 | -23.76% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $95.69 | -39.38% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $71.12 | -49.38% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.21 | +809.92% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.40 | +76.47% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $2.24 | +256,596.43% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $3.24 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $1.05 | +566.67% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $62.50 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.59 | - | 2 | Mar 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.93 | - | 1 | Nov 10, 2017 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $1.73
Upside: +73.41%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.17
Upside: +221.89%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $4.67
Upside: +28.48%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $3.06
Upside: +226.96%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.83
Upside: +233.17%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $7.31
Upside: +16.28%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.25
Upside: +220.00%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $1.93
Upside: +677.20%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.46
Upside: +2,499.65%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.87
Upside: +9.25%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $11.15
Upside: +16.59%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $41.30
Upside: -41.89%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $20.33
Upside: -23.76%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $95.69
Upside: -39.38%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $71.12
Upside: -49.38%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.21
Upside: +809.92%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $3.40
Upside: +76.47%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $2.24
Upside: +256,596.43%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $3.24
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $1.05
Upside: +566.67%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $62.50
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $0.59
Upside: -
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $4.93
Upside: -